Skip to content

Prevalence and Diagnostic Performance of the BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Cross-Sectional Study in Uruguay.

Oct 2026 · Acta Cytologica · pp. 1 · 0 citations
Medicine

TL;DR

Findings support the use of BRAF mutation testing may serve as a complementary tool in the diagnostic assessment of thyroid nodules and suggest its potential role as a complementary diagnostic tool in a Uruguayan population is evaluated.

View source

Similar papers

Open access Sep 2026

A Study of BRAF V600E Gene Mutation Among Patients With Follicular Cell–Derived Thyroid Malignant Neoplasms

RAF V600E expression was observed in 35.0% of cases and was predominantly associated with papillary thyroid carcinoma, which supports its diagnostic utility in differentiating papillary thyroid carcinoma from low-risk follicular-patterned lesions.

Kavya Sudarsan, Thanka Johnson, M. Preethi · 0 citations
Open access Oct 2026

Diagnostic performance of next-generation sequencing in thyroid nodules and molecular correlates of tumor aggressiveness in papillary thyroid carcinoma

Genetic alterations play a crucial role in the pathogenesis and progression of papillary thyroid carcinoma (PTC). However, the diagnostic and prognostic significance of specific genetic alterations in PTC remains to be elucidated. This study aimed to evaluate the diagnostic performance of next-generation sequencing...

Song-Ze Zhang, Nan Zhao, Lan Qin et al. · 0 citations
Review Open access Oct 2026

Diagnostic Accuracy of VE1 Immunohistochemistry for BRAF p.V600E in Colorectal Carcinoma: A Systematic Review

Background and Objectives: BRAF p.V600E status has diagnostic, prognostic, and therapeutic relevance in colorectal carcinoma. Molecular assays remain the reference methods, whereas mutation-specific BRAF (VE1 clone) immunohistochemistry offers a rapid tissue-based alternative. We evaluated VE1–molecular concordance and...

Ovidiu-Ioan Șușu, Marian Botoncea, Gabriel Serac et al. · 0 citations
Open access Sep 2026

BRAFV595E mutation detected across the disease spectrum from non-neoplastic urothelium to invasive urothelial carcinoma in dogs.

Objective The goal was to determine the presence of a driver mutation in dogs with and without detectable cancer to set the stage for future cancer prevention research exploiting processes that inhibit cancer development in the presence of such mutations. The objective was to detect the v-raf murine sarcoma viral oncog...

D. Dhawan, Mario F. Sola, Jennifer B. Nelson et al. · 0 citations
Review Open access Sep 2026

A Systematic Review on Clinical Features and Prognostic Significance of V600E Versus Non-V600E Braf Mutations in Colorectal Cancer

Objective: Colorectal cancer is the leading cause of global mortality. Recently, there has been interest in the molecular targets for treatment of cancer. B-rapidly expanded fibrosarcoma (BRAF) mutations, particularly V600E and nonV600E, are the common mutations with diverse clinical presentations and prognosis. The pr...

S. Agrawal, Suchismita Roy, Malati Nayak et al. · 0 citations
Open access Sep 2026

Preoperative Malignancy Risk Stratification in Bethesda IV Thyroid Nodules Using Integrated Clinical, Ultrasonographic, and Biochemical Parameters in Surgical Oncology Practice

Background and Objectives: Bethesda Category IV thyroid nodules present a diagnostic challenge due to their variable risk of malignancy and uncertain cytological features. Therefore, determining the risk of malignancy before surgery is important. This study aims to identify clinical, biochemical, and ultrasonographic f...

Y. Kahraman, İsmail Özer, M. Aydın et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.